ANG Lifesciences India Ltd has reported financial results for the period ended September 30, 2020.
Financial Results (H1 FY20-21)
The company has reported net sales of Rs.86.55 crores during the 6 months period ended September 30, 2020 as compared to Rs.68.49 crores during the period ended March 31, 2020.
The company has posted net profit of Rs.5.50 crores for the 6 months period ended September 30, 2020 as against Rs.3.25 crores for the 6 months period ended March 31, 2020.
The company has reported EPS of Rs.10.62 for the 6 months period ended September 30, 2020 as compared to Rs.6.27 for the 6 months period ended March 31, 2020.
Total Income | ₹ 86.55 crs | ₹ 68.49 crs | 26.37% |
Net Profit | ₹ 5.50 crs | ₹ 3.25 crs | 69.23% |
EPS | ₹ 10.62 | ₹ 6.27 | 69.38% |
Financial Results (H1 FY20-21) - YoY ComparisonThe company has reported net sales of Rs.86.55 crores during the 6 months period ended September 30, 2020 as compared to Rs.58.75 crores during the 6 months period ended September 30, 2019.
The company has posted net profit of Rs.5.50 crores for the 6 months period ended September 30, 2020 as against Rs.2.84 crores for the 6 months period ended September 30, 2019.
The company has reported EPS of Rs.10.62 for the 6 months period ended September 30, 2020 as compared to Rs.5.49 for the 6 months period ended September 30, 2019.
Total Income | ₹ 86.55 crs | ₹ 58.75 crs | 47.32% |
Net Profit | ₹ 5.50 crs | ₹ 2.84 crs | 93.66% |
EPS | ₹ 10.62 | ₹ 5.49 | 93.44% |
Source : Equity Bulls
Keywords